These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 7202363)
1. A new phthalidyl derivative of apovincaminic acid: (3 alpha,16 alpha)-eburnamenine-14 carboxylic acid phthalidyl ester (AF 698). A preliminary report on its chemical and pharmacological properties. Marzo A; Saccarello ML; Stradi R; Quadro E; Galzigna L; Tartarini S; Reali L Arzneimittelforschung; 1982; 32(6):601-3. PubMed ID: 7202363 [TBL] [Abstract][Full Text] [Related]
2. Effects of the new eburnamenine derivative RU 24722 on EEG recovery and cerebral energy metabolism after complete ischemia. Barzaghi F; Dragonetti M; Formento ML; Boissier JR Arzneimittelforschung; 1985; 35(2):472-7. PubMed ID: 4039569 [TBL] [Abstract][Full Text] [Related]
3. A comparison of some of the pharmacological properties of the new eburnamenine derivative vindeburnol with those of vincamine, vinburnine, dihydroergotoxine mesilate and nicergoline. Barzaghi F; Dragonetti M; Formento ML; Gueniau C; Nencioni A; Mantegazza P Arzneimittelforschung; 1986 Oct; 36(10):1442-8. PubMed ID: 3814205 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of vinca alkaloids and related compounds, XLIV: Synthesis of trifluoro-apovincaminic acid ester. Incze M; Sóti F; Kardos-Balogh Z; Kajtár-Peredy M; Szántay C Arch Pharm (Weinheim); 1990 Jun; 323(6):331-3. PubMed ID: 2396892 [TBL] [Abstract][Full Text] [Related]
5. Cerebral protective effects of VA-045, a novel apovincaminic acid derivative, in mice. Yamada S; Yamaguchi K; Okuyama S Res Commun Mol Pathol Pharmacol; 1994 Oct; 86(1):83-91. PubMed ID: 7850259 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacological evaluation of (nitrooxy)alkyl apovincaminates. Kawashima Y; Ikemoto T; Horiguchi A; Hayashi M; Matsumoto K; Kawarasaki K; Yamazaki R; Okuyama S; Hatayama K J Med Chem; 1993 Apr; 36(7):815-9. PubMed ID: 8464035 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous evaluation of apovincaminic acid esters and their metabolite apovincaminic acid by solvent partition and GLC in biological samples. Preliminary data with MR 711. Marzo A; Quadro G; Stradi R; Saccarello ML; Molteni L; Bruno G Arzneimittelforschung; 1981; 31(10):1681-4. PubMed ID: 7198444 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of vinca alkaloids and related compounds. Part 84. Sulfonamide derivatives of some vinca alkaloids with cardiovascular activity. Moldvai I; Temesvári-Major E; Szántay C; Tóth G; Kárpáti E; Szántay C Arch Pharm (Weinheim); 1997 Jun; 330(6):190-8. PubMed ID: 9264244 [TBL] [Abstract][Full Text] [Related]
9. [The influence of vincamine on global and regional cerebral blood flow in acute and subchronic human cerebral ischimia (author's transl)]. Herrschaft H Arzneimittelforschung; 1977; 27(6a):1278-84. PubMed ID: 578453 [TBL] [Abstract][Full Text] [Related]
10. Hemodynamic profile of a new cerebral vasodilator, vincamine and of one of its derivatives, apovincaminic acid ethylester (RGH-4405). Caravaggi AM; Sardi A; Baldoli E; Di Francesco GF; Luca TC Arch Int Pharmacodyn Ther; 1977 Mar; 226(1):139-48. PubMed ID: 869636 [TBL] [Abstract][Full Text] [Related]
11. In vivo effect of RU 24722 and drugs used for the treatment on senile cerebral insufficiency on rat brain ornithine decarboxylase. Cousin MA; Lando D; Gueniau C; Worcel M J Pharmacol; 1985; 16(1):31-43. PubMed ID: 3999751 [TBL] [Abstract][Full Text] [Related]
12. [Study of the antihypoxic effect of eburnamonine in acute and recurrent anoxia on the cerebral electric activity in curarized rats. Comparison with vincamine]. Van Den Driessche J; Linée P; Lacroix P; Le Pollès JB C R Seances Soc Biol Fil; 1977; 171(5):1081-7. PubMed ID: 146550 [TBL] [Abstract][Full Text] [Related]
13. Protective effects of vinpocetine and structurally related drugs on the lethal consequences of hypoxia in mice. King GA Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):299-307. PubMed ID: 3592869 [TBL] [Abstract][Full Text] [Related]
14. The synthesis of ethyl apovincaminate. Lörincz C; Szász K; Kisfaludy L Arzneimittelforschung; 1976; 26(10a):1907. PubMed ID: 1037211 [TBL] [Abstract][Full Text] [Related]
15. [32P-incorporation in adenosine phosphates of the rat brain after oral application of vincamine for 2 weeks (author's transl)]. Kanig K; Hoffmann KH Arzneimittelforschung; 1979; 29(1):33-4. PubMed ID: 582115 [TBL] [Abstract][Full Text] [Related]
16. Cerebral antioedematous effect of Teproside and of some vincamine derivatives. Borzeix MG; Cahn J Int J Clin Pharmacol Res; 1984; 4(4):259-61. PubMed ID: 6500773 [TBL] [Abstract][Full Text] [Related]
17. [Antihypoxic action of orotic acid]. Nikolova M; Nikolov R Eksp Med Morfol; 1981; 20(3):171-6. PubMed ID: 7308124 [TBL] [Abstract][Full Text] [Related]
18. In vivo antispasmodic activity of Sulcotidil. Roba J; Reuse-Blom S; Lambelin G Arch Int Pharmacodyn Ther; 1976 May; 221(1):54-9. PubMed ID: 962430 [TBL] [Abstract][Full Text] [Related]